FDA Adverse Event
Injury
Summary report: N
GORE EXCLUDER AAA ENDOPROSTHESIS
MDR report key: 1923564
·
Received December 10, 2010
Report
- Report Number
- 2017233-2010-00548
- Event Type
- Injury
- Date Received
- December 10, 2010
- Date of Event
- December 18, 2009
- Report Date
- December 9, 2010
- Manufacturer
- W.L. GORE & ASSOCIATES
- Product Code
- MIH
- PMA / PMN Number
- P020004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OH, US
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
EVAL: METHOD: A REVIEW OF THE MFG PAPERWORK HAS BEEN CONDUCTED. RESULTS: THE REVIEW OF THE MFG PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS. CONCLUSIONS: AS STATED IN THE GORE EXCLUDER AAA ENDOPROSTHESIS INSTRUCTIONS FOR USE, COMPLICATIONS THAT MAY OCCUR AND/OR REQUIRE INTERVENTION INCLUDE, BUT ARE NOT LIMITED TO, ENDOLEAK.
Description of Event or Problem · 1
ON (B)(6), 2007, THE PT WAS TREATED FOR AN ABDOMINAL AORTIC ANEURYSM USING GORE EXCLUDER AAA ENDOPROSTHESIS. ON (B)(6), 2009, A REINTERVENTION OCCURRED. A GORE EXCLUDER AAA ENDOPROSTHESIS WAS PLACED TO TREAT A PROXIMAL TYPE - 1 ENDOLEAK. NO FURTHER COMPLICATIONS HAVE BEEN REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | GORE EXCLUDER AAA ENDOPROSTHESIS | MIH / SYSTEM ENDOVASCULAR GRAFT AORTIC ANUERYSM TERATMENT | MIH | W.L. GORE & ASSOCIATES | WLG325 | 0460 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 69 YR | Hospitalization| R | ALLOPURINOL| FUROSEMIDE| BENAZDPRIL| MULTI-VITAMINS| POTASSIUM| ANTENOLOL |